250 results on '"Fietkau R"'
Search Results
2. Neutrophils Seeking New Neighbors - Radiotherapy Affects the Cellular Framework and the Spatial Organization in a Murine Breast Cancer Model
3. OA17.03 Real-World Outcomes with Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC (PACIFIC-R)
4. PO-2244 The effect of hyperthermia and radiation therapy sequence on the immune phenotype of breast cancer
5. MO-0797 Deep Learning-assisted delineation of brain metastases: a workflow focusing on AI-expert interaction
6. PO-1693 Deep learning for perspective deformation correction in X-ray imaging
7. OC-0830 Accelerated partial breast irradiation: 10-year results of a randomized GEC-ESTRO phase III trial
8. Induktionschemotherapie plus Doppelcheckpointblockade bei Plattenepithelkarzinomen des Kopf-Hals-Bereichs: Beurteilung des frühen Therapieansprechens mittels FDG-PET/CT
9. 58O Real-world overall survival (OS) with durvalumab (D) after chemoradiotherapy (CRT) in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): Interim analysis from the PACIFIC-R study
10. F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial
11. PD-0320 Two-ways validation of the feasibility of AI-based synthetic CT for MR-only brain radiotherapy
12. OC-0833 Total neoadjuvant therapy for Organ Preservation in Rectal Cancer: The CAO/ARO/AIO-16 phase II trial
13. OC-0631 Automatisation of catheter reconstruction in interstitial breast BT using electromagnetic tracking
14. 60P Machine learning based on blood biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy
15. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations
16. Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome
17. 912P Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
18. 1171MO PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
19. P14.20 Quality of life of patients with newly diagnosed glioblastoma during TTFields therapy in routine clinical care: first results of the TIGER study
20. Radioimmuntherapie
21. OC-0293 TNT in rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial
22. OC-0108 Impact of patient positioning on interstitial multicatheter HDR brachytherapy of the breast
23. PP-0146 Quality assurance of curved catheter paths in interstitial brachytherapy using a constructed phantom
24. First-line therapy of advanced head and neck cancer with double checkpoint blockade and radioimmunotherapy - first results.
25. OC-0109 Implant-based CT estimation towards adaptive breast brachytherapy
26. Erstlinientherapie fortgeschrittener Kopf-Hals-Karzinome mit Doppel-Checkpoint-Blockade und Radioimmuntherapie - erste Ergebnisse.
27. P14.16 The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors
28. Strahlentherapie in der Behandlung des Pankreaskarzinoms
29. Grundlagen der Strahlentherapie
30. Strahlentherapie von primären Lebertumoren und Lebermetastasen sowie Tumoren der Gallenwege
31. 302MO Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors
32. PO-1750: Comparison of MRI coils and RT-positioning systems for optimal MRI scanning in SRS cases
33. PO-1904: ROI optimisation for surface guided radiation therapy
34. PD-0170: Volumetric regression in brain metastases after stereotactic RT: Time course and significance
35. PD-0425: Radiomics for selection of patients treated with immuno-radiotherapy: pooled analysis from 6 studies
36. R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial
37. 1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
38. SUPRATOL: Eine multizentrische Versorgungsstudie zur funktionellen Evaluation der transoralen Lasermikrochirurgie (TLM) des supraglottischen Larynxkarzinoms
39. SUPRATOL: a multicenter trial to evaluate functional results of transoral laser microsurgery (TLM) in patients with supraglottic carcinomas.
40. 11. Kombinierte Radiochemotherapie: Indikationen und Ergebnisse
41. Adjuvante und neoadjuvante Radiochemotherapie des Rektumkarzinoms — Präliminare Ergebnisse des Protokolls CAO/ARO/AIO 94 / Adjuvant and Neoadjuvant Radiochemotherapy in Rectal Cancer: Preliminary Results Protocol CAO/ARO/AIO 94
42. Operatives Vorgehen nach neoadjuvanter Radiochemotherapie beim Rektumkarzinom
43. Neoadjuvante Radiochemotherapie beim fortgeschrittenen, primär nicht resektablen Pankreaskarzinom
44. Einfluß der neoadjuvanten Radiochemotherapie auf operative Therapie und postoperative Komplikationen beim fortgeschrittenen Rektumkarzinom — präliminäre Ergebnisse einer prospektiv randomisierten Studie
45. Behandlung von Mundhöhlenmalignomen mittels enoraler Resektion und interstitieller Radiotherapie
46. Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)
47. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial
48. EP1.01-49 Histology-Depended Pattern of Patho-Histological Response After Induction Therapy in Locally Advanced Non-Small Cell Lung Cancer
49. Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial)
50. R0-resection following chemotherapy or chemoradiation improves survival of primary inoperable pancreatic cancer patients. Interim results of the CONKO-007 prospective randomized multicenter trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.